Related Experiment Video

Updated: Feb 16, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.9K

[Targeting Notch1 Gene Inhibits the Proliferation of Multiple Myeloma Cells]

Mei-Ling Li1, Mei-Qiong Chen2, Peng Zhang2

  • 1Department of Hematology, Xiamen University Zhongshan Hospital, Xiamen 361004, Fujian Province, China; Department of Hematology, Guizhou Medical University Third Hospital, Duyun 558000, Guizhou Province, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|December 22, 2017
PubMed
Abstract

Insights

Notch1 gene silencing inhibits multiple myeloma cell proliferation and induces apoptosis. This suggests Notch1 signaling is a potential therapeutic target for multiple myeloma treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Multiple myeloma is a hematologic malignancy characterized by uncontrolled proliferation of plasma cells.
  • The Notch1 signaling pathway plays a role in cell growth and survival, making it a potential target for cancer therapy.

Purpose of the Study:

  • To investigate the impact of Notch1 gene silencing on multiple myeloma cell proliferation and apoptosis.
  • To explore Notch1 as a potential therapeutic target for multiple myeloma.

Main Methods:

  • Utilized Notch1-shRNA to silence the Notch1 gene in RPMI8226 multiple myeloma cells.
  • Assessed cell proliferation using CCK-8 assays and apoptosis via flow cytometry.
  • Analyzed Notch1 mRNA and protein expression, along with downstream signaling proteins (Hes-1, Jagged-1, Jagged-2, BCL-2, PTEN, AKT, P-AKT) using real-time PCR and Western blot.

Main Results:

  • Notch1 gene silencing significantly reduced Notch1 mRNA and protein expression in myeloma cells.
  • Observed a significant decrease in cell proliferation and a significant increase in apoptosis following Notch1 silencing.
  • Noted downregulation of Hes1, p-AKT, and BCL-2, and upregulation of PTEN expression.

Conclusions:

  • Notch1 gene silencing effectively inhibits multiple myeloma cell proliferation and induces apoptosis.
  • The mechanism involves the activation of PTEN and modulation of the p-AKT signaling pathway.
  • Notch1 signaling represents a promising therapeutic target for multiple myeloma.

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.7K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.5K

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K